Quick Answer
Kodiak Sciences Inc. reported Diluted EPS of $4.32 per share (loss) for fiscal year 2025.
Kodiak Sciences Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$4.32 | -29.0% |
| 2024 | -$3.35 | +32.6% |
| 2023 | -$4.97 | +22.2% |
| 2022 | -$6.39 | -23.8% |
| 2021 | -$5.16 | -77.3% |
| 2020 | -$2.91 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.16 | -38.1% | -12.6% |
| June 30, 2025 | -$1.03 | -19.8% | +5.5% |
| March 31, 2025 | -$1.09 | -32.9% | -29.8% |
| September 30, 2024 | -$0.84 | +11.6% | +2.3% |
| June 30, 2024 | -$0.86 | +43.8% | -4.9% |
| March 31, 2024 | -$0.82 | +39.3% | +13.7% |
| September 30, 2023 | -$0.95 | +35.4% | +37.9% |
| June 30, 2023 | -$1.53 | +12.1% | -13.3% |
- Kodiak Sciences Inc. showed a decrease of -29.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, Kodiak Sciences Inc.’s diluted eps has declined by 48.5% (from $2.91 per share (loss) to $4.32 per share (loss)).
- The most recent figure is from Kodiak Sciences Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: